|
|
Volumn 9, Issue 7, 2013, Pages 1119-1120
|
|
Dual inhibition of autophagy and the AKT pathway in prostate cancer
a
a
|
|
Author keywords
AKT inhibitor; Autophagy; Cell survival; Combination therapy; Prostate cancer
|
|
Indexed keywords
3 METHYLADENINE;
AZD 5363;
BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL;
CHLOROQUINE;
PROTEIN KINASE B;
PROTEIN KINASE B INHIBITOR;
SMALL INTERFERING RNA;
STAUROSPORINE;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
AUTOPHAGOSOME;
AUTOPHAGY;
BIODEGRADATION;
CELL CYCLE REGULATION;
CELL PROLIFERATION;
ENZYME INHIBITION;
LYSOSOME;
PHASE 1 CLINICAL TRIAL (TOPIC);
PROSTATE CANCER;
RNA INTERFERENCE;
AKT INHIBITOR;
AUTOPHAGY;
CELL SURVIVAL;
COMBINATION THERAPY;
PROSTATE CANCER;
ADENINE;
AUTOPHAGY;
CELL LINE, TUMOR;
CHLOROQUINE;
CLINICAL TRIALS, PHASE I AS TOPIC;
HUMANS;
MACROLIDES;
MALE;
PROSTATIC NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-AKT;
PYRIMIDINES;
PYRROLES;
SIGNAL TRANSDUCTION;
|
|
EID: 84880861312
PISSN: 15548627
EISSN: 15548635
Source Type: Journal
DOI: 10.4161/auto.24921 Document Type: Article |
|
Times cited : (44)
|
|
References (0)
|
